Comparison of the Effects of Tocilizumab and High-dose Steroid Treatment on Treatment Response and Mortality in Hospitalized COVID-19 Pneumonia Patients with Cytokine Storm
Objective: Cytokine storm associated with coronavirus disease-2019 (COVID-19) is a major contributor to COVID-19-related mortality.This study aimed to evaluate and compare the clinical and laboratory effects, as well as mortality outcomes, of high-dose steroid therapy versus tocilizumab treatment in patients experiencing this hyperinflammatory state.Method: This retrospective, single-center cohort study analyzed the records of 200 patients who were hospitalized at University of Health Sciences Turkey, Gazi Yaargil Training and Research Hospital with COVID-19 pneumonia and diagnosed with a cytokine storm between February 1 and September 30, 2021.Eligibility criteria required that Ama: Koronavirs hastal-2019 (COVID-19) ile ilikili sitokin frtnas sendromu, hastalkla ilikili mortalitenin nemli bir nedenidir.Bu almada; sitokin frtnas gelien hastalarda; yksek doz steroidler ile tosilizumabn klinik ve laboratuvar sonular ile mortalite zerindeki etkilerini karlatrmay amaladk.
Authors
- Ömer Faruk Alakuş (ORCID: https://orcid.org/0000-0003-4039-1256)
- Osman Uzundere (ORCID: https://orcid.org/0000-0002-5968-4561)
- Mahsum Ozan (ORCID: https://orcid.org/0000-0002-3181-7684)
- İhsan Solmaz (ORCID: https://orcid.org/0000-0002-6624-8063)
- Serhat Kaya (ORCID: https://orcid.org/0000-0001-6936-7394)
- Şafak Kaya (ORCID: https://orcid.org/0000-0001-9912-7340)
- Fethullah Kayan (ORCID: https://orcid.org/0000-0002-8875-5672)
- Cengiz Demır (ORCID: https://orcid.org/0000-0001-9856-184X)
Publication Details
- Journal
- Bagcilar Medical Bulletin
- Published
- 2025-12-03
- DOI
- https://doi.org/10.4274/bmb.galenos.2025.30602
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00